{
    "patient": {
        "Name": "Cameron Moore",
        "DateOfBirth": "1986-04-08",
        "Sex": "Female",
        "Diagnosis": "Invasive ductal carcinoma",
        "BodyPart": "Breast",
        "Physician": "Dr. Troy Sosa",
        "TreatingInstitution": "Cline Inc"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Breast",
            "CollectedDate": "2023-09-07",
            "ReceivedDate": "2023-09-08",
            "TumorPercentage": "93%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-09-12",
            "ReceivedDate": "2023-09-12"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "B2M",
                "DNA Alteration": "c.2T>G",
                "GeneMutation": "p.M1R Stopgain-LOF",
                "VariantAlleleFraction": "17.61%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "HBB",
                "DNA Alteration": "c.364G>C",
                "GeneMutation": "p.E7K Spliceregionvariant-LOF",
                "VariantAlleleFraction": "27.4%"
            },
            {
                "Gene": "NOTCH1",
                "DNA Alteration": "c.7398del",
                "GeneMutation": "p.E122K Spliceregionvariant-GOF",
                "VariantAlleleFraction": "23.28%"
            },
            {
                "Gene": "CCND3",
                "DNA Alteration": "c.766_776del11",
                "GeneMutation": "p.E27K Spliceregionvariant-GOF",
                "VariantAlleleFraction": "24.74%"
            },
            {
                "Gene": "HDAC2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R256fs*64 Frameshift-LOF",
                "VariantAlleleFraction": "5.19%"
            },
            {
                "Gene": "ERCC2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.E7V Stopgain-LOF",
                "VariantAlleleFraction": "9.61%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "EZH2",
            "PTCH1",
            "SRSF2",
            "STAT5B"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "29 m/Mb",
            "Tmbpercentile": "46%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "High"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}